Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
NZ shares hit record, led by Pushpay

52m nzherald.co.nz
New Zealand shares hit another record amidst a slew of earnings, with Trade Me Group and A2 Milk Co gaining on their annual accounts while Fletcher Building dropped.
TME TRMEF FBU WBC FCREY SPKKY NZTCY SPK NZTCF WEBNF WBK FRCEF WBC PPSHY FBU TME TDMEY MEZ

0
Markets Live: Australian shares set to fall

7h theage.com.au
The benchmark S&P500 reached new record highs overnight, as the record bull run on Wall Street continued but futures are pointing to a negative start for the ASX.
FBU FBU FCREY CCLAY CCL CCLAF FRCEF

0
Markets Live: Australian shares set to fall

7h smh.com.au
The benchmark S&P500 reached new record highs overnight, as the record bull run on Wall Street continued but futures are pointing to a negative start for the ASX.
FBU FBU FCREY CCLAY CCL CCLAF FRCEF

0
Fletcher full-year result out: $190m loss

10h nzherald.co.nz
Fletcher Building has made a $190 million loss, only the second time since listing on the NZX in 2001 that it has lost money.
FBU SKC FBU FCREY FRCEF

0
Market poised for Fletcher full-year result

11h nzherald.co.nz
Fletcher Building's annual result for the full year result is due out this morning, with investors saying they are focusing on the outlook commentary.
FBU SKC FBU FCREY FRCEF

0
NZ shares at fresh high, Vector, A2 gain

2018-08-21 nzherald.co.nz
New Zealand shares inched to a fresh record ahead of tomorrow's bumper results day, led higher by Vector and A2 Milk Co.
FBU FBU PPSHY FCREY NZTCY SPKKY SPK NZTCF FRCEF MEZ

0
Record-breaking NZ sharemarket poised for Big Wednesday

2018-08-20 nzherald.co.nz
The record-breaking New Zealand sharemarket is poised to take in the good, the bad and the fair-to-middling tomorrow when a slew of results from the country's top corporates are due.
FBU FBU ANZLY AIR FCREY ANZFF ANZFY FRCEF MEZ AIZ

0
Competition tsar Rod Sims turns Hawk on dodgy sports club merchandise

2018-08-16 theage.com.au
ACCC chairman Rod Sims managed to gate crash one of the busiest days of reporting season after sin binning 21 AFL and rugby league clubs over their returns policies in relation to dodgy merchandise.
FBU FBU TLS FCREY TTRAF FRCEF TLSYY

0
Competition tsar Rod Sims turns Hawk on dodgy sports club merchandise

2018-08-16 smh.com.au
ACCC chairman Rod Sims managed to gate crash one of the busiest days of reporting season after sin binning 21 AFL and rugby league clubs over their returns policies in relation to dodgy merchandise.
FBU FBU TLS FCREY TTRAF FRCEF TLSYY

0
NZ shares rise as Skellerup posts record profit

2018-08-16 nzherald.co.nz
New Zealand shares rose, led higher by a record profit from Skellerup Holdings, as investors focused more on domestic earnings than volatility in global markets. Precinct Properties New Zealand also gained.
CEN AIA FBU FCREY SPKKY NZTCY SPK NZTCF ACKDF FRCEF AUKNY COENY COENF AOTUF SKC AIA FBU CEN SKLUY SKL PFGTF SML

0
Women making moves in infrastructure

2018-08-15 nzherald.co.nz
For Ariana Stuart, joining the industry as a law graduate at the height of the GFC brought its own set of challenges. She took on further study, before eventually getting interested in infrastructure, especially on procurement and project advice and dispute resolution. Since joining Kensington Swan in 2013, she has grown to specialise in resolving construction and infrastructure disputes, including currently working on the largest leaky building claim in the country.
FBU FBU FCREY FRCEF

0
Model for the future should involve sharing the risk

2018-08-15 nzherald.co.nz
Fletcher Building chief executive Ross Taylor says it's encouraging to see the Government engaging with the construction industry and the companies that work on the larger projects to understand the present issues and work together to develop a sustainable way forward.
FBU FBU FCREY FRCEF

0
NZ shares bounce back led by Synlait Milk

2018-08-14 nzherald.co.nz
New Zealand shares bounced back from some of yesterday's sell-off as investors are yet to see serious contagion from Turkey's burgeoning financial crisis, led higher by Synlait Milk and A2 Milk Co. Summerset Group Holdings fell after reporting first-half earnings.
AIR FCREY NZTCF ACKDF ANZFY AUKNY AIZ SKT SYKWF SKKTY SNZ SML AIA FBU SPKKY NZTCY SPK FRCEF PGW KWIPF PGWFY AIA FBU ANZLY ANZFF PGWFF MEZ PFGTF

0
Comment: How to spend a billion dollars

2018-08-13 nzherald.co.nz
You might've seen some headlines recently, with capital figures that defy belief - such as Uber raising a USD$9 billion (NZ$13.65 billion) investment round earlier this year.
FBU FBU FCREY FRCEF

0
Fletcher starts sale process for Formica, private equity firms likely bidders, report says

2018-08-12 nzherald.co.nz
The sales process for Fletcher Building's Formica unit is about to get underway, and is most likely to attract the interest of private equity buyers, the Australian newspaper reported.
FBU FBU FCREY FRCEF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: AN6341605